Diabetes Mellitus Clinical Trial
Official title:
Using CERS to Optimize Quality of Life for Persons With Diabetes and Chronic Pain
As many as 75% of people with diabetes report chronic pain. While cognitive behavioral therapy (CBT) improves pain and functioning in individuals with chronic pain, many rural and underserved communities lack resources for such programs. The investigators tested the hypothesis that a CBT-based program delivered by community health workers (CHW) can improve quality of life in individuals with diabetes and chronic pain.
Diabetes mellitus (DM) is a growing chronic disease, affecting 20% of the population of
Alabama. However, type 2 DM (90-95% of all DM) rarely occurs in isolation; 25% of all
Americans report chronic pain, rising to 58-70% of community-dwellers over age 65. The
National Center for Health Statistics reported in 2006 that chronic pain affected 76.2
million Americans, more than cancer, heart disease, stroke and DM combined. Despite the high
prevalence of chronic pain, evidence suggests that under treatment is common. In one study,
68% of primary care physicians estimated that chronic pain was inadequately managed in their
patients, and 60% thought improving physician education could help. Indeed, 40% of people
with moderate to severe pain report not getting adequate relief.
Chronic pain is a significant barrier to successful DM self-care; patients with chronic pain
have lower medication adherence and are less likely to exercise. Fully 60-80% of DM patients
report chronic pain, and in our ENCOURAGE pilot study (Safford, PI), all but one participant
did so. About 20-25% of pain may stem from neuropathy, but at least 1/3 stems from OA
(osteoarthritis), and coexistence of multiple causes is common. Over half of patients >65
and 60% of women of any age report OA, demonstrating the very high prevalence of OA in this
demographic group. Pain management dominated 20% of primary care visits for diabetic
patients in one study, and decreased the likelihood of DM risk factor management. Not
surprisingly, depressive symptoms are common in individuals with OA and chronic pain, and
are also associated with non adherence to DM self-care behavior. Pain is therefore a barrier
to not only quality of life, but to successful DM self-care.
While cognitive behavioral therapy (CBT) improves pain and functioning in individuals with
chronic pain, many rural and underserved communities lack resources for such programs. The
investigators tested the hypothesis that a CBT-based program delivered by community health
workers (CHW) can improve quality of life in individuals with diabetes and chronic pain.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03743779 -
Mastering Diabetes Pilot Study
|
||
| Completed |
NCT03786978 -
Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus
|
N/A | |
| Completed |
NCT01804803 -
DIgital Assisted MONitoring for DiabeteS - I
|
N/A | |
| Completed |
NCT05039970 -
A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Completed |
NCT04068272 -
Safety of Bosentan in Type II Diabetic Patients
|
Phase 1 | |
| Completed |
NCT03243383 -
Readmission Prevention Pilot Trial in Diabetes Patients
|
N/A | |
| Completed |
NCT03730480 -
User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS)
|
N/A | |
| Recruiting |
NCT02690467 -
Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm.
|
N/A | |
| Completed |
NCT02229383 -
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
|
Phase 3 | |
| Completed |
NCT06181721 -
Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes
|
N/A | |
| Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
| Recruiting |
NCT04489043 -
Exercise, Prediabetes and Diabetes After Renal Transplantation.
|
N/A | |
| Withdrawn |
NCT03319784 -
Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients
|
Phase 4 | |
| Completed |
NCT03542084 -
Endocrinology Auto-Triggered e-Consults
|
N/A | |
| Completed |
NCT02229396 -
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo
|
Phase 3 | |
| Recruiting |
NCT05544266 -
Rare and Atypical Diabetes Network
|
||
| Completed |
NCT01892319 -
An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
|
||
| Completed |
NCT05031000 -
Blood Glucose Monitoring Systems: Discounter Versus Brand
|
N/A | |
| Recruiting |
NCT04039763 -
RT-CGM in Young Adults at Risk of DKA
|
N/A |